Developers scramble to fix issues with national COVID vaccine booking platform Confusion over the site’s launch date has seen general practices bear the brunt of people demanding coronavirus vaccination appointments.
Peak medical bodies want COVID vaccine booking clarity With general practices already inundated with calls ahead of next week’s rollout, the RACGP and AMA have urged the Federal Government to clarify the process and ‘not build unrealistic expectations’ for patients.
Fears AstraZeneca pause in Europe could give rise to vaccine hesitancy in Australia At least 13 countries have raised the alarm about possible links between the coronavirus vaccine and blood clots. How will GPs address these concerns with patients?
COVID a ‘stimulus’ for increased uptake of secure messaging But is the Australian healthcare system ready?
Criticism of GPs’ refusal to treat some infant patients in-person a ‘cheap shot’ Many GPs who ask that young patients be tested for COVID-19 before treating them in-person believe they are simply following state-issued health advice.
Federal Government responds to calls to extend telehealth The extension is part of $1.1 billion in funding to ‘build on Australia’s existing response to COVID-19’.
‘Uncharacteristic’ Queensland CHO letter leaves GPs confused Dr Jeanette Young encouraged GPs to see more patients face-to-face, including those with respiratory symptoms, suggesting a lack of in-person consultations has led to a rise in ED presentations.
‘No biological reason’ to link blood clots to COVID vaccine Despite this, several European countries have paused their rollout of the Oxford University/AstraZeneca vaccine as a precaution.
Questions over company selected for national COVID vaccine booking system Concerns relate to HealthEngine’s past misuse of patient data, the selection process, impact on competition, and the need for a national online booking system.
Anaphylaxis found to affect 0.025% of COVID-19 mRNA vaccine recipients New research utilising real-world data suggests the rate is largely comparable to most antibiotics.